Daniel Gerlach: Essential Clinical Trial Insights Ahead of ASCO 2026
Daniel Gerlach/X

Daniel Gerlach: Essential Clinical Trial Insights Ahead of ASCO 2026

Daniel Gerlach, Associate Scientific Director, Computational Biology Oncology at Boehringer Ingelheim, shared a post on LinkedIn:

“Heading to ASCO26 – looking forward to an exciting meeting!

Time to be prepared with Bishal Gyawali’s recent article on how to read a clinical trial report: here.

ASCO Annual Meeting 2026 here.”

Daniel Gerlach

Other articles about ASCO Annual Meeting 2026 on OncoDaily.